Ideaya Biosciences Inc (IDYA): Eigentümerstruktur
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 52,385 US Dollar | 12 | 3 | 1 | 0 | 0 |
| #Shares | Short [%] | Short Ratio |
| 96.489.484 | 10,93 | 9,87 |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name Ideaya Biosciences Inc
Mitarbeiter 145
Handelsplatz NASDAQ
Ticker Symbol IDYA
IPO Datum 2019-05-23
Adresse 5000 Shoreline Court, South San Francisco, CA, United States, 94080
Webseite https://www.ideayabio.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Mr. Yujiro S. Hata | Founder, President, CEO & Chairman |
| 2 | Dr. Joshua Bleharski M.B.A., Ph.D. | Chief Financial Officer |
| 3 | Mr. Andres Ruiz Briseno CPA | Chief Accounting Officer |
| 4 | Mr. Douglas B. Snyder | Chief Legal Officer |
| 5 | Dr. Michael A. White Ph.D. | President of Research & Development |
| 6 | Dr. Darrin M. Beaupre M.D., Ph.D. | Chief Medical Officer |
| 7 | Dr. Paul A. Barsanti Ph.D. | Chief Technology Officer |
| 8 | Ms. Francine Zelaya | Senior VP & Head of Human Resources |
| 9 | Mr. Mick O'Quigley | Senior Vice President of Medical Writing & Project Management |
| 10 | Mr. Daniel A. Simon | Chief Business Officer |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | FMR Inc | 14,62% | 0,48 Mrd. USD |
| 2 | BlackRock Inc | 9,22% | 0,30 Mrd. USD |
| 3 | Jupiter Topco LLC | 8,89% | 0,29 Mrd. USD |
| 4 | HHG PLC | 7,53% | 0,25 Mrd. USD |
| 5 | Capital Research Global Investors | 5,54% | 0,18 Mrd. USD |
| 6 | Baker Bros Advisors LP | 5,19% | 0,17 Mrd. USD |
| 7 | State Street Corp | 4,71% | 0,15 Mrd. USD |
| 8 | Vanguard Capital Management, LLC | 4,28% | 0,14 Mrd. USD |
| 9 | Logos Global Management LP | 3,11% | 0,10 Mrd. USD |
| 10 | Adage Capital Partners Gp LLC | 2,81% | 0,09 Mrd. USD |
| 11 | Deerfield Management Co | 2,81% | 0,09 Mrd. USD |
| 12 | Geode Capital Management, LLC | 2,51% | 0,08 Mrd. USD |
| 13 | T. Rowe Price Associates, Inc. | 2,29% | 0,08 Mrd. USD |
| 14 | Morgan Stanley - Brokerage Accounts | 2,00% | 0,07 Mrd. USD |
| 15 | Dimensional Fund Advisors, Inc. | 1,72% | 0,06 Mrd. USD |
| 16 | AllianceBernstein L.P. | 1,69% | 0,06 Mrd. USD |
| 17 | Fiera Capital Corporation | 1,50% | 0,05 Mrd. USD |
| 18 | Federated Hermes Inc | 1,48% | 0,05 Mrd. USD |
| 19 | GSK PLC | 1,38% | 0,05 Mrd. USD |
| 20 | BNP Paribas Investment Partners SA | 1,32% | 0,04 Mrd. USD |